Speakers

Stuart Curbishley

Chief Manufacturing & Development Officer • adthera bio

Stuart was awarded his PhD by the University of Birmingham in 2005 after which his group developed a programme of early-phase clinical trials, leading the development of dendritic cell therapy for primary liver cancer. Stuart directed the University of Birmingham’s GMP manufacturing unit, overseeing the development of new ATMPs, extending to T cell products, stromal cells, chondrocytes, and dendritic cells. Now playing a leading role in developing Adthera bio, Stuart brings his expertise in closing manufacturing processes and developing sustainable, scalable solutions to the projects his team work on.

Also speaking

Katrien Reynders

Board Member • Holland BIO

Becky Johnson-Kent

DIRECTOR OF COMMERCIAL PARTNERSHIPS AND HEAD OF WOMEN IN ADVANCED THERAPIES • Phacilitate

Sofia Venceslau

Senior Project Manager • ReciBioPharm

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.